Concepedia

Fiona Elwood

FE

9

Publications

887

Citations

9

H-Index

2013

Active since

Affiliations

Novartis (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Harvard University

Fiona Elwood is an author at Novartis (United States) specializing in medicine, neurodegeneration, and neurodegenerative diseases.

ORCID

Top concepts

Publications per year

2013–2025

9

Publications

9

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Simon Dujardin, Caitlin Commins, Aurélien Lathuilière et al. · Nature Medicine · 2020 · 427 citations · Full text

, , +9

Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival

Jian Luo, Fiona Elwood, Markus Britschgi et al. · The Journal of Experimental Medicine · 2013 · 272 citations · Full text

A proteogenomic view of Parkinson’s disease causality and heterogeneity

Sérgio Kaiser, Luqing Zhang, Brit Mollenhauer et al. · npj Parkinson s Disease · 2023 · 51 citations · Full text

, , +16

Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor

Fiona Elwood, David J. Witter, Jennifer Piesvaux et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 32 citations

Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons

C García Sánchez, Christopher M. Acker, Audrey Gray et al. · Communications Biology · 2021 · 28 citations · Full text

Rows per page

1–5 of 9